Name
Neomed OÜ
Registry code
12032034
VAT number
EE101417592
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
23.12.2010 (13)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
78201 - Temporary employment agency activities
2 400 €
-6 039 €
-252%
449 €
(estimate is approximate)
52 795 €
1
Submitted
No tax arrears
-11%
-11%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Katre Talgre 02.05.1982 (42) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
| 2019 20.06.2020 | 2020 17.06.2021 | 2021 24.06.2022 | 2022 13.06.2023 | 2023 14.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 3 004 € | 3 430 € | 3 000 € | 800 € | 2 400 € |
| Net profit (loss) for the period | 1 117 € | 2 267 € | 1 626 € | 102 € | -6 039 € |
| Profit Margin | 37% | 66% | 54% | 13% | -252% |
| Current Assets | 54 516 € | 56 810 € | 59 512 € | 59 714 € | 53 682 € |
| Fixed Assets | 722 € | 411 € | 100 € | 0 € | - |
| Total Assets | 55 238 € | 57 221 € | 59 612 € | 59 714 € | 53 682 € |
| Current Liabilities | 399 € | 115 € | 880 € | 880 € | 887 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 54 839 € | 57 106 € | 58 732 € | 58 834 € | 52 795 € |
| Employees | 0 | 0 | 0 | 0 | 1 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 492.36 € | 526.12 € | 1 |
| 2023 Q4 | - | 713.88 € | 764.28 € | 1 |
| 2023 Q3 | 800 € | 856.38 € | 764.28 € | 1 |
| 2023 Q2 | 800 € | 227.27 € | 91.29 € | 1 |
| 2023 Q1 | 800 € | 128.05 € | - | - |
| 2022 Q4 | - | - | - | - |
| 2022 Q3 | 800 € | 150 € | - | - |
| 2022 Q2 | - | - | - | - |
| 2022 Q1 | - | - | - | - |
| 2021 Q4 | - | - | - | - |
| 2021 Q3 | - | - | - | - |
| 2021 Q2 | 800 € | 109.41 € | - | - |
| 2021 Q1 | 2 300 € | 431.8 € | - | - |
| 2020 Q4 | 1 300 € | 172.43 € | - | - |
| 2020 Q3 | 750 € | 136.08 € | - | - |
| 2020 Q2 | 1 380 € | 259.95 € | - | - |
| 2020 Q1 | 1 564 € | 296.14 € | - | - |
